Polycystic Kidney Disease

BASICS

BASICS

BASICS

DESCRIPTION

DESCRIPTION

DESCRIPTION

  • A group of monogenic disorders that results in renal cyst development
  • Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD)
  • ADPKD is one of the most common human genetic disorders.

EPIDEMIOLOGY

EPIDEMIOLOGY

EPIDEMIOLOGY

  • ADPKD is generally late onset with end-stage kidney disease (ESKD) developing in older adults.
  • ARPKD is usually present in infants.

Prevalence

Prevalence

Prevalence

As ESKD, ADPKD: 8.7/1 million in the United States; 7/1 million in Europe

ETIOLOGY AND PATHOPHYSIOLOGY

ETIOLOGY AND PATHOPHYSIOLOGY

ETIOLOGY AND PATHOPHYSIOLOGY

  • ADPKD results from PKD1 and PKD2 mutations, which encode for polycystin 1 (PC1) and polycystin 2 (PC2). The disrupted polycystin function results in fluid-filled cysts that progressively increase in size, leading to gross enlargement of the kidney, and distortion of the renal architecture.
  • ARPKD secondary to PKHD1 mutations

Genetics

Genetics

Genetics

  • ADPKD: autosomal dominant inheritance
    • PKD1 on chromosome 16p13.3 (85% of patients) encodes PC1.
    • PKD2 on chromosome 4q21 (15% of patients) encodes PC2.
  • ARPKD: autosomal recessive inheritance
    • Gene PKHD1 on chromosome 6p21.1–p12 encodes fibrocystin.

RISK FACTORS

RISK FACTORS

RISK FACTORS

Family history

GENERAL PREVENTION

GENERAL PREVENTION

GENERAL PREVENTION

Genetic counseling

COMMONLY ASSOCIATED CONDITIONS

COMMONLY ASSOCIATED CONDITIONS

COMMONLY ASSOCIATED CONDITIONS

  • ADPKD
    • Cysts in other organs
      • Polycystic liver disease in 58% of young age group to 94% of 45-year-olds
      • Pancreatic (5%); seminal (40%); arachnoid (8%)
    • Vascular manifestations
      • Intracerebral aneurysms in 6% of patients without family history and in 16% with family history
      • Aortic root dilation, dissections
    • Cardiac manifestations:
      • Mitral valve prolapse (25%); left Ventricular Hypertrophy
    • Diverticular disease
  • ARPKD: liver involvement: affected in inverse proportion to renal disease; congenital hepatic fibrosis with portal HTN

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.